Inbec Tablet

Inbec Tablet is a combination antiretroviral medication containing Abacavir, Dolutegravir, and Lamivudine, used for the treatment and long-term management of HIV (Human Immunodeficiency Virus) infection in adults and adolescents aged 12 years and older who weigh at least 40 kg. Abacavir and Lamivudine belong to the nucleoside reverse transcriptase inhibitor (NRTI) class, while Dolutegravir is an integrase inhibitor that helps prevent HIV from multiplying in the body. By reducing the amount of HIV in the bloodstream, Inbec Tablet helps strengthen the immune system and lowers the risk of HIV-related illnesses and complications. For optimal results, patients should take the medication exactly as prescribed and should not stop or alter the dosage without consulting their healthcare provider. Common side effects may include headache, nausea, diarrhea, fatigue, and difficulty sleeping, while serious adverse reactions are uncommon but require immediate medical attention. Widely prescribed for HIV treatment, Inbec Tablet plays an important role in improving quality of life and supporting long-term viral control when used consistently under medical supervision.